Source: PR Newswire

Press Release: AbbVie : AbbVie and Allergan Receive Second Request from Federal Trade Commission on Pending Transaction

NORTH CHICAGO, Ill., Sept. 27, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that, as expected, AbbVie and Allergan (NYSE: AGN) have each received a Request for Additional Information (Second Request) from the Federal Trade...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from AbbVie's latest SEC filings

Annual Revenue

Based on data from AbbVie's latest SEC filings


Richard A. Gonzalez's photo - Chairman & CEO of AbbVie

Chairman & CEO

Richard A. Gonzalez

CEO Approval Rating


AbbVie discovers, develops and markets both biopharmaceuticals and small molecule drugs.

AbbVie's headquarters is located...
Read more